podophyllotoxin has been researched along with Acute Lymphoid Leukemia in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 13 (56.52) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hijiya, N; Hudson, MM; Ness, KK; Ribeiro, RC | 1 |
| Allard, A; Chompret, A; de Vathaire, F; Diallo, I; Haddy, N; Lassalle, M; Le Deley, MC; Lefkopoulos, D; Quiniou, E; Rubino, C; Samsaldin, A | 1 |
| Debeljak, M; Dolžan, V; Erčulj, N; Faganel Kotnik, B; Jazbec, J | 1 |
| Langebrake, C; Reinhardt, D; Ritter, J | 1 |
| Behm, FG; Cheng, C; Gajjar, A; Hijiya, N; Jeha, S; Liu, W; Pui, CH; Raimondi, SC; Relling, MV; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sandlund, JT; Zhang, Z | 1 |
| Crowther, D; Ghielmini, M; Morgenstern, GR; Pettengell, R; Radford, JA; Scheid, C; Stern, PL | 1 |
| Pui, CH; Ribeiro, RC; Rivera, GK | 1 |
| Kamen, BA; Weitman, SD; Winick, NJ | 1 |
| Kobayashi, K; Ratain, MJ | 1 |
| Rubinstein, L; Smith, MA; Ungerleider, RS | 1 |
| Bowman, WP; Croce, CM; Felix, CA; Lange, BJ; Negrini, M; Winick, NJ | 1 |
| Crist, WM; Pui, CH; Rivera, GK | 1 |
| Murphy, SB | 1 |
| Bowman, LC; Brenner, MK; Hale, GA; Heslop, HE; Krance, RA; Pui, CH; Rochester, RA | 1 |
| Amylon, MD; Bash, RO; Behm, FG; Camitta, B; Chen, C; Felix, CA; Kamen, BA; Pui, CH; Raimondi, SC; Relling, MV; Shuster, JJ; Winick, NJ; Woo, MH | 1 |
| Head, D; Mathew, S; Raimondi, SC; Rubnitz, JE | 1 |
| Estlin, EJ; Lowis, SP; Yule, SM | 1 |
| Behm, FG; Evans, WE; Hancock, ML; Head, DR; Mahmoud, MH; Pui, CH; Raimondi, SC; Ribeiro, RC; Rivera, GK; Sandlund, JT | 1 |
| Pui, CH | 1 |
| Björkholm, M | 1 |
| Evans, WE; Kavanagh, RL; Ochs, J; Rivera, GK; Rodman, JH; Sunderland, M; Yalowich, J | 1 |
| Beck, WT; Danks, MK; Deneka, DA; Schmidt, CA | 1 |
| Bezanilla Regato, JL; Moya Calderón, E; Navajas Gutiérrez, A; Piñán, MA | 1 |
7 review(s) available for podophyllotoxin and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.
Topics: Adolescent; Adult; Child; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 2009 |
Minimising the long-term adverse effects of childhood leukaemia therapy.
Topics: Alkylating Agents; Anthracyclines; Antimetabolites; Antineoplastic Agents; Asparaginase; Asparagine; Cardiovascular Diseases; Child; Clinical Trials as Topic; Glucocorticoids; Gonadal Disorders; Humans; Leukemia; Leukemia, Myeloid, Acute; Osteonecrosis; Podophyllotoxin; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tretinoin; Vinca Alkaloids | 2002 |
"Above all do no harm:" horizons in pediatric oncology.
Topics: Bone Marrow Transplantation; Child; Combined Modality Therapy; Growth Substances; Humans; Leukemia, Myeloid, Acute; Medical Oncology; Mercaptopurine; Methotrexate; Pediatrics; Phenotype; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quality of Life; Recurrence; Survival Rate | 1994 |
Pharmacodynamics and long-term toxicity of etoposide.
Topics: Child; Etoposide; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Neoplasms; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Testicular Neoplasms | 1994 |
Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
Topics: Alkylating Agents; Cell Cycle; Child; Chromosomes, Human, Pair 11; Clinical Trials as Topic; Drug Administration Schedule; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Lymphoma, Non-Hodgkin; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk Factors; Topoisomerase II Inhibitors; Translocation, Genetic | 1994 |
Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
Topics: Antineoplastic Agents; Child; Cyclophosphamide; Cytarabine; Humans; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction | 2001 |
Etoposide and teniposide in the treatment of acute leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1990 |
3 trial(s) available for podophyllotoxin and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child, Preschool; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Neoplasm Recurrence, Local; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Treatment Outcome; Vincristine | 2004 |
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk Factors; Teniposide | 1991 |
Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Drug Administration Schedule; Humans; Infusions, Intravenous; Leucovorin; Metabolic Clearance Rate; Methotrexate; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1990 |
13 other study(ies) available for podophyllotoxin and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Role of radiation dose in the risk of secondary leukemia after a solid tumor in childhood treated between 1980 and 1999.
Topics: Adolescent; Algorithms; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Bone Marrow; Case-Control Studies; Child; Child, Preschool; Dose-Response Relationship, Radiation; Female; France; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Likelihood Functions; Male; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Risk Assessment | 2010 |
DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia.
Topics: Adolescent; Alleles; Anthracyclines; Antineoplastic Agents; Case-Control Studies; Cell Cycle Proteins; Child; Child, Preschool; DNA Repair; DNA-Binding Proteins; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Infant; Male; Neoplasms, Second Primary; Nuclear Proteins; Podophyllotoxin; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy; Risk Factors; Survival Analysis | 2012 |
Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukapheresis; Lymphocyte Count; Lymphocyte Subsets; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Mesna; Middle Aged; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Treatment Outcome; Vincristine | 1995 |
Retrieval therapy for isolated CNS relapse in childhood acute lymphoblastic leukemia.
Topics: Brain Neoplasms; Child; Humans; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 1995 |
Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.
Topics: Child, Preschool; Chromosomes, Human, Pair 11; DNA-Cytosine Methylases; DNA, Neoplasm; Etoposide; Humans; Leukemia, Monocytic, Acute; Male; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic | 1993 |
The epipodophyllotoxins: both sides of the coin.
Topics: Acute Disease; Child; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1993 |
Secondary acute myeloid leukemia following treatment with epipodophyllotoxins.
Topics: Acute Disease; Child; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Failure | 1993 |
Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies.
Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Treatment Outcome | 1999 |
Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies.
Topics: Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Genotype; Glutathione Transferase; Humans; Leukemia, Myeloid, Acute; Male; Mixed Function Oxygenases; Neoplasms, Second Primary; Podophyllotoxin; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; United States | 2000 |
Concurrent translocations of MLL and CBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia.
Topics: Child, Preschool; Chromosome Breakage; Core Binding Factor Alpha 2 Subunit; DNA-Binding Proteins; Female; Histone-Lysine N-Methyltransferase; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins; Proto-Oncogenes; Transcription Factors; Translocation, Genetic | 2000 |
Therapy-related myeloid leukaemia.
Topics: Acute Disease; Child; Humans; Leukemia, Myeloid; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 1990 |
Increased ATP requirement for activity of and complex formation by DNA topoisomerase II from human leukemic CCRF-CEM cells selected for resistance to teniposide.
Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Amsacrine; Cell Line; Cell Nucleus; DNA Topoisomerases, Type I; DNA, Neoplasm; Drug Resistance; Humans; Kinetics; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Teniposide; Tumor Cells, Cultured | 1989 |
[Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
Topics: Child; Child, Preschool; Cytarabine; Drug Combinations; Female; Humans; Male; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Risk Factors; Teniposide | 1988 |